Table S3.
Meta-regression analyses of the associations between pretreatment LMR and survival among OC patients
| Coefficient | Standard error | T-value | P-value | 95% CI of intercept | |
|---|---|---|---|---|---|
|
| |||||
| OS | |||||
| Year of publication | 0.0820097 | 0.2491714 | 0.33 | 0.749 | (–0.4731787, 0.6371981) |
| Age | −0.0738882 | 0.0200856 | −3.68 | 0.004 | (−0.1186417, −0.0291346) |
| Sample size | −0.0008594 | 0.0005413 | −1.59 | 0.143 | (−0.0020655, 0.0003466) |
| LMR cutoff value | 0.2008357 | 0.129754 | 1.55 | 0.153 | (−0.0882742, 0.4899455) |
| NOS score | −0.1728062 | 0.1330581 | −1.30 | 0.223 | (−0.4692782, 0.1236658) |
| PFS | |||||
| Year of publication | −0.1952826 | 0.2098772 | −0.93 | 0.388 | (−0.7088336, 0.3182684) |
| Age | −0.0333006 | 0.0275148 | −1.21 | 0.272 | (−0.1006267, 0.0340256) |
| Sample size | −0.0000113 | 0.0004759 | −0.02 | 0.982 | (−0.0011757, 0.0011531) |
| LMR cutoff value | 0.0189409 | 0.1054612 | 0.18 | 0.863 | (−0.2391134, 0.2769952) |
| NOS score | −0.1618594 | 0.0787455 | −2.06 | 0.086 | (−0.3545426, 0.0308238) |
Abbreviations: LMR, lymphocyte-to-monocyte ratio; NOS, Newcastle–Ottawa Scale; OC, ovarian cancer; OS, overall survival; PFS, progression-free survival.